Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2015 08:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Change in Executive Team

PALO ALTO, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), today announced that Rajiv Patni, M.D., chief development officer, has decided to step down from his position...
April 30, 2015 08:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Reports Pipeline Progress and First Quarter 2015 Financial Results

Strong Enrollment in STOP-HE Trial Conference Call and Webcast at 10:00 a.m. ET PALO ALTO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage...
April 22, 2015 16:43 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Report Pipeline Progress and First Quarter 2015 Financial Results

PALO ALTO, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
April 01, 2015 17:03 ET | Source: Ocera Therapeutics, Inc.

Ocera Completes Interim Analysis of OCR-002 in Phase 2b STOP-HE Study for the Treatment of Acute Hepatic Encephalopathy

PALO ALTO, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
March 11, 2015 16:01 ET | Source: Ocera Therapeutics, Inc.

Ocera Reports Fourth Quarter and Full Year 2014 Financial Results

PALO ALTO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
March 02, 2015 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Announce Fourth Quarter and Full Year 2014 Financial Results

PALO ALTO, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
February 23, 2015 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at 35th Annual Cowen and Company Health Care Conference

PALO ALTO, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
February 18, 2015 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Announces Preliminary Topline Results From Phase 2a Investigator-Sponsored Study of OCR-002

PALO ALTO, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX) today announced preliminary topline results from a Phase 2a investigator-sponsored study evaluating the...
December 03, 2014 08:01 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Promotes Michael Byrnes to Chief Financial Officer

PALO ALTO, Calif., Dec. 3, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical-stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
November 13, 2014 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Reports Third Quarter 2014 Financial Results

PALO ALTO, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right